Lee Chan Henry (CIK 1980648) reported 81 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-13). Recent activity: Buy ONC (812 shares), Buy ONC (1,058 shares), Buy ONC (796 shares), Sell ONC (2,666 shares), Sell ONC (1,044 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-13 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 812 | $157,910 |
| 2026-08-13 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 1,058 | $225,693 |
| 2026-08-13 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 796 | $126,588 |
| 2026-08-13 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 2,666 | $959,760 |
| 2026-08-03 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 1,044 | $337,932 |
| 2026-07-24 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 514 | $99,958 |
| 2026-07-24 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 665 | $141,858 |
| 2026-07-24 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 490 | $77,925 |
| 2026-07-24 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 1,669 | $542,425 |
| 2026-07-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 664 | $200,833 |
| 2026-07-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 266 | $56,743 |
| 2026-07-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 196 | $31,170 |
| 2026-07-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 202 | $39,283 |
| 2026-06-18 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 590 | $156,925 |
| 2026-06-15 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 45,071 | $0 |
| 2026-06-15 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 428 | $110,268 |
| 2026-06-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 711 | $192,138 |
| 2026-06-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 160 | $43,401 |
| 2026-05-15 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 101 | $19,641 |
| 2026-05-15 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 133 | $28,372 |
| 2026-05-15 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 98 | $15,585 |
| 2026-05-15 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Sell | 332 | $103,159 |
| 2026-04-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 101 | $19,641 |
| 2026-04-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 133 | $28,372 |
| 2026-04-10 | BeOne Medicines Ltd. (ONC) | SVP, General Counsel | Buy | 98 | $15,585 |
Source: SEC Form 4 filings · as of 2026-08-13